Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2014

Guerrero-Preston R, Michailidi C, Marchionni L, Pickering CR, Frederick MJ, Myers JN, et al. Key tumor suppressor genes inactivated by "greater promoter" methylation and somatic mutations in head and neck cancer. Epigenetics. 2014;9(7):1031-46.

Gandhi MD, Evens AM, Fenske TS, Hamlin P, Coiffier B, Engert A, et al. Pancreatitis in patients treated with brentuximab vedotin: a previously unrecognized serious adverse event. Blood. 2014;123(18):2895-7.

Laginestra MA, Piccaluga PP, Fuligni F, Rossi M, Agostinelli C, Righi S, et al. Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specified. Blood Cancer J. 2014;4:259.

Cohen C, Lawson D, Jiang J, Siddiqui MT. Automated in situ hybridization for human papilloma virus. Appl Immunohistochem Mol Morphol. 2014;22(8):619-22.

2013

Zhao Z, Moley KH, Gronowski AM. Diagnostic potential for miRNAs as biomarkers for pregnancy-specific diseases. Clin Biochem. 2013;46(10-11):953-60.

Bonetti P, Testoni M, Scandurra M, Ponzoni M, Piva R, Mensah AA, et al. Deregulation of ETS1 and FLI1 contributes to the pathogenesis of diffuse large B-cell lymphoma. Blood. 2013;122(13):2233-41.

Pflueger D, Sboner A, Storz M, Roth J, Compérat E, Bruder E, et al. Identification of molecular tumor markers in renal cell carcinomas with TFE3 protein expression by RNA sequencing. Neoplasia. 2013;15(11):1231-40.

Zhang Y, Lee ET, Howard BV, Best LG, Umans JG, Yeh J, et al. Insulin resistance, incident cardiovascular diseases, and decreased kidney function among nondiabetic American Indians: the Strong Heart Study. Diabetes Care. 2013;36(10):3195-200.

Kim SS, Magro C, Granstein RD, Bass A, Erkan D. Systemic Lupus Erythematosus Associated with Rowell's Syndrome: A Clinical Pathology Conference Held by the Division of Rheumatology at Hospital for Special Surgery. HSS J. 2013;9(3):289-92.

Rink M, Park K, Volkmer BG, Xylinas E, Hansen J, Cha EK, et al. Loss of SPINK1 expression is associated with unfavorable outcomes in urothelial carcinoma of the bladder after radical cystectomy. Urol Oncol. 2013;31(8):1716-24.